Korean Journal of Clinical Pharmacy

Table. 3. Table 3

Priority of pharmaceutical care service R&D agendas

Rank	Agenda code	Total	Publicity		Improvement of service		Economic efficiency		Service characteristics

			Innovativeness	Public welfare	Quality improvement	Practical Application	Growth potential	Reduction in Cost	Patient safety	Patient centeredness
1	H3	0.692	0.641	0.625	0.727	0.730	0.762	0.721	0.701	0.703
2	C2	0.689	0.671	0.694	0.662	0.694	0.696	0.709	0.713	0.680
3	P4	0.668	0.692	0.674	0.651	0.742	0.696	0.613	0.678	0.611
4	H2	0.666	0.681	0.605	0.673	0.706	0.740	0.685	0.678	0.668
5	C1	0.661	0.681	0.644	0.684	0.670	0.652	0.685	0.655	0.634
6	C8	0.625	0.529	0.674	0.597	0.646	0.596	0.661	0.608	0.588
7	H1	0.613	0.580	0.575	0.608	0.646	0.629	0.613	0.655	0.634
8	C7	0.607	0.569	0.625	0.564	0.599	0.607	0.625	0.643	0.611
9	H7	0.602	0.610	0.575	0.619	0.611	0.596	0.625	0.620	0.588
10	H4	0.593	0.600	0.605	0.597	0.587	0.530	0.565	0.585	0.622
11	H9	0.592	0.570	0.585	0.597	0.551	0.574	0.613	0.608	0.634
12	P1	0.592	0.641	0.635	0.619	0.491	0.596	0.553	0.550	0.622
13	H8	0.590	0.569	0.545	0.597	0.623	0.652	0.613	0.585	0.599
14	P2	0.589	0.590	0.615	0.564	0.563	0.585	0.589	0.608	0.588
15	H10	0.589	0.651	0.575	0.619	0.527	0.552	0.577	0.585	0.645
16	P3	0.589	0.600	0.585	0.597	0.634	0.530	0.613	0.585	0.541
17	H11	0.572	0.539	0.545	0.597	0.539	0.541	0.601	0.620	0.599
18	C5	0.532	0.519	0.535	0.553	0.551	0.475	0.565	0.503	0.507
19	H13	0.521	0.559	0.516	0.521	0.563	0.530	0.505	0.468	0.519
20	H12	0.506	0.570	0.496	0.499	0.563	0.585	0.433	0.468	0.495
21	C3	0.498	0.569	0.545	0.467	0.431	0.453	0.541	0.491	0.472
22	C6	0.494	0.529	0.515	0.467	0.479	0.475	0.493	0.503	0.484
23	H5	0.490	0.468	0.466	0.510	0.443	0.486	0.469	0.538	0.553
24	H6	0.475	0.488	0.476	0.499	0.419	0.486	0.421	0.549	0.472
25	C4	0.360	0.427	0.426	0.326	0.359	0.354	0.301	0.292	0.346

R&D, research and development